Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial.
about
Potential for developing purinergic drugs for gastrointestinal diseasesManaging patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasisNew Oral Therapies for Psoriasis: A Comprehensive ReviewA₃ adenosine receptor allosteric modulator induces an anti-inflammatory effect: in vivo studies and molecular mechanism of action.In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists.Current status and future prospects for biologic treatments of psoriasis.Update on psoriasis immunopathogenesis and targeted immunotherapy.Current investigational drugs in psoriasis.Systemic therapies for psoriasis: an evidence-based update.Investigational drugs for treating psoriatic arthritis.G protein-coupled receptors in rheumatology.Emerging oral drugs for psoriasis.Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration.Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.Small molecules and antibodies for the treatment of psoriasis: a patent review (2010-2015).Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.More Biologic Therapies Expected To Treat Advanced Plaque Psoriasis.Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis.Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A3 Adenosine Receptor Agonist Piclidenoson.[Psoriatic arthritis : Drugs of the (near) future].Psoriasis
P2860
Q27000719-D6CD084B-9A64-4B86-9920-6FC2F73E9420Q27693878-7ED717B7-0270-4B51-9CB2-22A8A5C862CBQ28071475-1A5892DC-15FC-4D66-AF97-96BFC7DB5A0CQ34412639-C8BAC0DD-01B7-43B6-BF4C-DD3C8B6CCB92Q34701441-4E74B4DF-3ED3-4476-AD63-DFF9712F1E67Q36057909-20D59278-5FF2-4920-8632-5FD61A3D2BD6Q36445919-349DF659-1B9E-46C7-B4F5-98F82AE5615AQ37991748-68C4AC5A-3793-46C8-A58E-67A1D407B08AQ38185297-14FB9F8F-1B50-4CF7-BE7B-BF6531EC04C5Q38206551-91951C05-AC71-49FA-9E95-718A7B23F280Q38209549-D10F561C-2D4F-4355-ABAE-735A228FAD24Q38341175-E5E920BD-B067-4792-94F5-F55B0379DFDDQ38691042-EBBDB88E-3E91-4D1A-B8FA-B249780AFC12Q38753877-1A4B55F3-A1CB-4BC0-9C35-AB383B6D3508Q38856226-3966A296-3E53-49D3-9B30-C00D19B0645CQ39004042-7245A2B6-6210-46D0-9D44-7F38982D54EAQ39418010-5B77A32B-8FD0-4F50-B110-BCDEC65608B3Q41967507-DB607443-E6A5-4CCD-8C2E-E4D1AA4D36DCQ48132042-5D7FC208-AFDB-4A74-A37E-AA788B9F9A6FQ54974227-4A61030A-8508-42FB-A558-55E1379E1521Q54998108-B09B3931-976C-4748-A550-FE5A9BCFE673Q58235909-2EF527DA-B950-4C56-BEA9-24D5DFF32B26
P2860
Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Treatment of plaque-type psori ...... omized phase 2 clinical trial.
@ast
Treatment of plaque-type psori ...... omized phase 2 clinical trial.
@en
type
label
Treatment of plaque-type psori ...... omized phase 2 clinical trial.
@ast
Treatment of plaque-type psori ...... omized phase 2 clinical trial.
@en
prefLabel
Treatment of plaque-type psori ...... omized phase 2 clinical trial.
@ast
Treatment of plaque-type psori ...... omized phase 2 clinical trial.
@en
P2093
P1476
Treatment of plaque-type psori ...... omized phase 2 clinical trial.
@en
P2093
D Gospodinov
F Pavlotsky
M H Silverman
M Kadurina
P304
P356
10.1111/J.1468-3083.2011.04078.X
P577
2011-04-20T00:00:00Z